RenovoRx
IA Gemcitabine Provides Survival Benefit in Patients with Locally Advanced Pancreatic Cancer
SG Tylor
Source – RenovoRx The interim results of the Phase III TIGeR-PaC study (NCT03257033) presented at the 2023 European Society of ...
Source – RenovoRx The interim results of the Phase III TIGeR-PaC study (NCT03257033) presented at the 2023 European Society of ...